These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9496567)

  • 41. [Screening and treatment of acute hepatitis C].
    Grangé JD
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):285-7. PubMed ID: 12700513
    [No Abstract]   [Full Text] [Related]  

  • 42. Dramatic improvement of watermelon stomach with alpha-interferon.
    Disdier P; Schleinitz N; Perreard M; Monges D; Swiader L; Gérolami A; Harlé JR; Weiller PJ
    Am J Gastroenterol; 1995 Jun; 90(6):1009-10. PubMed ID: 7771396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retreatment of hepatitis C patients who do not respond to interferon: the search continues.
    Pianko S; McHutchison J
    Am J Gastroenterol; 2000 May; 95(5):1122-4. PubMed ID: 10811315
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hepatitis B and C: current therapy].
    Bruch HR; Höhner U; Müller R
    Praxis (Bern 1994); 1998 Oct; 87(42):1408-12. PubMed ID: 9824948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Viral hepatitis C in patients with renal disease].
    Contreras AM
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S88-92. PubMed ID: 12712863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
    Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preventing hepatitis B and hepatitis C virus infections in end-stage renal disease patients: back to basics.
    Kellerman S; Alter MJ
    Hepatology; 1999 Jan; 29(1):291-3. PubMed ID: 9862883
    [No Abstract]   [Full Text] [Related]  

  • 48. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
    Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
    J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnosis and treatment of viral hepatitis C].
    Bogomolov BP; Kostiunina MK
    Klin Med (Mosk); 1997; 75(9):62-4. PubMed ID: 9432548
    [No Abstract]   [Full Text] [Related]  

  • 50. How should we treat hepatitis C in 1997?
    Williams CN
    Can J Gastroenterol; 1997; 11(4):291-2. PubMed ID: 9218852
    [No Abstract]   [Full Text] [Related]  

  • 51. [A study of HCV infection in patients with chronic hemodialysis without blood transfusion].
    Kaneko K; Iijima T; Satoh T; Kinoshita E; Nambu M
    Kansenshogaku Zasshi; 1993 Nov; 67(11):1140-1. PubMed ID: 8270807
    [No Abstract]   [Full Text] [Related]  

  • 52. Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse.
    Poignet JL; Degos F; Bouchardeau F; Chauveau P; Courouce AM
    J Hepatol; 1995 Dec; 23(6):740-1. PubMed ID: 8750175
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hepatitis C following kidney transplantation].
    Rostaing L; Izopet J; Modesto-Segonds A
    Presse Med; 1998 Apr; 27(14):684-8. PubMed ID: 9767928
    [No Abstract]   [Full Text] [Related]  

  • 54. [The advances in the treatment of chronic hepatitis C with interferon].
    Liu TH; Fu XX; Tian GS
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):650-2. PubMed ID: 1306461
    [No Abstract]   [Full Text] [Related]  

  • 55. [Appearance of antiphospholipid antibodies in patients with hepatitis C treated with interferon-alpha].
    Doutre MS; Baquey A; Bernard P; Couzigou P; Bernard N; Lacoste D; Morlat P
    Ann Med Interne (Paris); 1997; 148(1):99-100. PubMed ID: 9137700
    [No Abstract]   [Full Text] [Related]  

  • 56. [Interferon-alpha and development of psoriatic arthropathy].
    Piqueras Alcol B; de Diego Lorenzo A; Pérez Roldán F; Baños Díaz E; Clemente Ricote G
    An Med Interna; 1996 Oct; 13(10):512-3. PubMed ID: 9019204
    [No Abstract]   [Full Text] [Related]  

  • 57. [Hepatitis C. A review on clinical aspects, diagnosis, therapy and prevention].
    Kallinowski B; Theilmann L
    Krankenpfl J; 1993; 31(1-2):38-40. PubMed ID: 8445876
    [No Abstract]   [Full Text] [Related]  

  • 58. Tolerance and pharmacokinetics of high doses of interferon-alpha-2a in a hemodialysis patient.
    Izzedine H; Lebon P; Launay-Vacher V; Hamani A; Deray G
    Nephron; 2001 Jan; 87(1):91-2. PubMed ID: 11174033
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic hepatitis C after renal transplantation. Treatment with alpha-interferon.
    Chan TM; Lok AS; Cheng IK; Ng IO
    Transplantation; 1993 Nov; 56(5):1095-8. PubMed ID: 8249107
    [No Abstract]   [Full Text] [Related]  

  • 60. Interferon and hepatitis C.
    Terrault N; Wright T
    N Engl J Med; 1995 Jun; 332(22):1509-11. PubMed ID: 7739691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.